Thousand Oaks pharma giant Amgen Inc. is making a series of C-suite changes, triggered by the retirement announcement of Chief Technology Officer David Reese. Reese, 63, is retiring effective June 1. He has served as the company’s first chief technology officer since 2023. Sean Bruich, the current senior vice president of artificial intelligence and data, will be taking over the chief technology officer post on June 1. These changes are in turn …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.